Free Trial
→ “Fed Proof” Your Bank Account with THESE 4 Simple Steps (From Weiss Ratings) (Ad) Free ORKA Stock Alerts

Oruka Therapeutics (ORKA) SEC Filings & 10K Form

Oruka Therapeutics logo
$9.91 -0.24 (-2.36%)
Closing price 03/3/2025 04:00 PM Eastern
Extended Trading
$9.93 +0.02 (+0.20%)
As of 03/3/2025 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Oruka Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/27/2025
5:42 PM		Koh Bong Y (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2025
5:42 PM		Koh Bong Y (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:43 PM		Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/05/2025
3:00 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:44 PM		Agarwal Arjun (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:41 PM		Klein Lawrence Otto (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:42 PM		Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Quinlan Paul T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:43 PM		Goncalves Joana (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
6:16 AM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
11:15 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form EFFECT
11/21/2024
5:30 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:30 PM		Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D/A
11/14/2024
6:38 PM		Avidity Partners Management LP (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
4:49 PM		Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:20 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2024
3:56 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
11:04 AM		Allostery Investments LP (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:56 AM		JANUS HENDERSON GROUP PLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
5:37 AM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/13/2024
3:01 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
3:15 PM		Adage Capital Management, L.P. (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D/A
10/18/2024
3:11 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form DEF 14A
10/07/2024
10:37 AM		FMR LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G
10/04/2024
3:05 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:55 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:57 PM		Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D/A
09/06/2024
4:00 PM		Klein Lawrence Otto (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:01 PM		Agarwal Arjun (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:02 PM		Goncalves Joana (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:03 PM		Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Quinlan Paul T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:04 PM		BALL KRISTINE M (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:05 PM		Dambkowski Carl (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:06 PM		Kulkarni Samarth (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:07 PM		Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Turtle Cameron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:07 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest III L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:08 PM		Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D
09/05/2024
4:18 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
4:57 PM		ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Ma-Weaver Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
6:51 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
6:53 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
08/23/2024
3:35 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

You MUST act before March 17th.
08/20/2024
1:23 PM		ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
JANUS HENDERSON GROUP PLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:25 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:27 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
08/15/2024
3:15 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:17 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
08/09/2024
7:35 AM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
08/01/2024
3:30 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
07/26/2024
9:50 AM		ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
JANUS HENDERSON GROUP PLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
11:15 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form EFFECT
07/24/2024
3:49 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form ARS
07/22/2024
4:17 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-4/A
07/12/2024
6:38 PM		ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
JANUS HENDERSON GROUP PLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
6:10 PM		ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
JANUS HENDERSON GROUP PLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
4:29 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-4/A
07/09/2024
4:01 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
4:04 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
07/05/2024
4:20 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
06/18/2024
4:17 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-4/A
06/06/2024
3:45 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
05/13/2024
8:11 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
04/29/2024
6:28 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
04/25/2024
3:27 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
04/23/2024
3:20 PM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
4:29 PM		Allostery Investments LP (Filed by)
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G
04/11/2024
8:51 AM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
04/09/2024
7:57 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Avidity Partners Management LP (Filed by)
Form SC 13G
04/05/2024
6:38 PM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Western Standard LLC (Filed by)
Form SC 13G/A
04/03/2024
6:31 AM		ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
6:33 AM		ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ORKA) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...
Crypto Swap Profits | Sponsored
Leaked Trump video exposes his secret stocks
Ten investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...
Porter & Company | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Elon Social Security shock?
“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...
Altimetry | Sponsored
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Trump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out
This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...
American Alternative | Sponsored